;
Skip to main content
Home > Week in Review > Sales & Marketing

Chronological Index of : Sales and Marketing

 Current Issue
  • bioMerieux, Quest Diagnostics sales and marketing update

    bioMerieux S.A. (Euronext:BIM), Marcy lEtoile, France Quest Diagnostics Inc. (NYSE:DGX), Madison, N.J. Business: Pharmacogenetics Quest launched bioMerieuxs THxID BRAF test in the U.S. to detect BRAF V600E and V600K …

    Published on 6/30/2014
  • Medivir sales and marketing update

    Medivir AB (SSE:MVIR B), Huddinge, Sweden Business: Infectious Medivir launched Olysio simeprevir in Sweden, Finland and Denmark and said the HCV drug will be available in all Nordic countries within the next few weeks…

    Published on 6/30/2014
  • Takeda sales and marketing update

    Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Autoimmune Takeda launched Entyvio vedolizumab in the U.S. to treat moderate to severe ulcerative colitis (UC) and moderate to severe Crohns disease (…

    Published on 6/30/2014
  • Bio-Rad Laboratories Inc sales and marketing update

    Bio-Rad Laboratories Inc. (NYSE:BIO), Hercules, Calif. Business: Diagnostic Bio-Rad launched outside of the U.S. its BioPlex 2200 HIV Ag-Ab kit, which detects HIV antigens and antibodies and differentiates between HIV-1…

    Published on 6/23/2014
  • Cepheid Inc sales and marketing update

    Cepheid Inc. (NASDAQ:CPHD), Sunnyvale, Calif. Business: Diagnostic Cepheid launched its Xpert Carba-R test in countries that recognize CE Mark approval to detect carbapenemase-producing Gram-negative bacteria. The list …

    Published on 6/23/2014
  • Forest Laboratories Inc sales and marketing update

    Forest Laboratories Inc. (NYSE:FRX), New York, N.Y. Business: Neurology Forest said it will now continue marketing its 5 and 10 mg tablets of immediate-release Namenda memantine for Alzheimers disease into this fall to …

    Published on 6/23/2014
  • GenomeDx Biosciences Inc sales and marketing update

    GenomeDx Biosciences Inc., Vancouver, B.C. Business: Diagnostic GenomeDx said U.S. healthcare PPO network Prime Health Services Inc. will cover GenomeDxs Decipher Prostate Cancer Classifier. GenomeDx markets Decipher…

    Published on 6/23/2014
  • Invitae Corp sales and marketing update

    Invitae Corp., San Francisco, Calif. Business: Cancer Invitae launched its hereditary pancreatic cancer panel worldwide. The test, which analyzes 17 genes associated with an increased risk of pancreatic cancer with an …

    Published on 6/23/2014
  • Novo Nordisk A/ sales and marketing update

    Novo Nordisk A/S (CSE:NVO; NYSE:NVO), Bagsvaerd, Denmark Business: Endocrine/Metabolic Novo Nordisk launched in the U.S. its Levemir FlexTouch, a prefilled disposable insulin pen containing Levemir insulin detemir, a …

    Published on 6/23/2014
  • Takeda Pharmaceutical Co. Ltd sales and marketing update

    Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Gastrointestinal Takeda launched Takelda aspirin/lansoprazole fixed-dose combination tablets in Japan to reduce the risk of thrombosis and embolism in …

    Published on 6/23/2014
  • Tissue Regenix Group pl sales and marketing update

    Tissue Regenix Group plc (LSE:TRX), York, U.K. Business: Dermatology Tissue Regenix launched DermaPure in the U.S. to treat chronic wounds. Tissue Regenix also said it signed an exclusive government supplier agreement …

    Published on 6/23/2014
  • Vertex Pharmaceuticals Inc sales and marketing update

    Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), Boston, Mass. Business: Pulmonary Vertex signed a letter of intent with the pan-Canadian Pricing Alliance (pCPA) to enable public reimbursement of Kalydeco ivacaftor to treat …

    Published on 6/23/2014
  • Werfen Group S.A sales and marketing update

    Werfen Group S.A., Barcelona, Spain Business: Diagnostic Werfens Inova Diagnostics Inc. subsidiary launched its Quanta Lite Calprotectin assay worldwide to aid in diagnosing inflammatory bowel disease (IBD). The …

    Published on 6/23/2014
  • Alvogen, Celltrion, Hospira sales and marketing update

    Alvogen Inc., Pinebrook, N.J. Celltrion Inc. (KOSDAQ:068270), Incheon, South Korea Hospira Inc. (NYSE:HSP), Lake Forest, Ill. Business: Biosimilars, Autoimmune Alvogen launched Inflectra infliximab, a biosimilar of …

    Published on 2/17/2014
  • Cardiome, Phoenix Pharmahandel sales and marketing update

    Cardiome Pharma Corp. (TSX:COM; NASDAQ:CRME), Vancouver, B.C. Phoenix Pharmahandel GmbH & Co. KG, Mannheim, Germany Business: Cardiovascular Cardiome's Correvio GmbH subsidiary granted Phoenix Pharmahandels Tamro AB …

    Published on 2/17/2014
  • Covis, GlaxoSmithKline sales and marketing update

    Covis Pharma S.a.r.l., Zug, Switzerland GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Cardiovascular Covis launched 0.0625 and 0.1875 mg strengths of Lanoxin digoxin in the U.S. to treat mild to …

    Published on 2/17/2014
  • Foundation Medicine, AmerisourceBergen Corp. sales and marketing update

    Foundation Medicine Inc. (NASDAQ:FMI), Cambridge, Mass. AmerisourceBergen Corp. (NYSE:ABC), Valley Forge, Pa. Business: Pharmacogenetics AmerisourceBergen's Ion Solutions pharmaceuticals arm selected Foundation Medicine…

    Published on 2/17/2014
  • Icahn School of Medicine at Mount Sinai sales and marketing update

    Icahn School of Medicine at Mount Sinai, New York, N.Y. Business: Neurology The medical school launched a carrier screening test for spinal muscular atrophy (SMA). The test detects silent carriers with two copies of the…

    Published on 2/17/2014
  • Illumina, Rubicon sales and marketing update

    Illumina Inc. (NASDAQ:ILMN), San Diego, Calif. Rubicon Genomics Inc., Ann Arbor, Mich. Business: Diagnostic, Genomics Rubicon launched the PicoPlex DNA-seq kits worldwide for use with Illumina's next-generation …

    Published on 2/17/2014
  • Nuvo, Mallinckrodt sales and marketing update

    Nuvo Research Inc. (TSX:NRI), Mississauga, Ontario Mallinckrodt plc (NYSE:MNK), St. Louis, Mo. Business: Neurology Mallinckrodt launched Pennsaid 2% diclofenac in the U.S. to treat pain associated with osteoarthritis (…

    Published on 2/17/2014
  • SkyePharma, Mundipharma sales and marketing update

    SkyePharma plc (LSE:SKP), London, U.K. Mundipharma International Ltd., Cambridge, U.K. Business: Inflammation, Drug delivery SkyePharma said Mundipharma launched flutiform fluticasone/formoterol in France to treat …

    Published on 2/17/2014
  • Theravance, GlaxoSmithKline sales and marketing update

    Theravance Inc. (NASDAQ:THRX), South San Francisco, Calif. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Pulmonary Theravance disclosed in its 2013 financial results that GlaxoSmithKline launched …

    Published on 2/17/2014
  • Aerocrine, Healthcare 21 Ltd. sales and marketing update

    Aerocrine AB (SSE:AERO), Solna, Sweden Healthcare 21 Ltd., Cork, Ireland Business: Diagnostic Aerocrine granted Healthcare 21 exclusive rights to market Niox Vero and Niox Mino in the U.K. and Ireland. Niox Mino and …

    Published on 1/27/2014
  • Alexza, Ferrer sales and marketing update

    Alexza Pharmaceuticals Inc. (NASDAQ:ALXA), Mountain View, Calif. Grupo Ferrer Internacional S.A., Barcelona, Spain Business: Neurology Ferrer launched Adasuve Staccato loxapine in Spain. The launch triggered a $1 …

    Published on 1/27/2014
  • Angelini, Helsinn sales and marketing update

    Gruppo Angelini, Rome, Italy Helsinn Healthcare S.A., Pazzallo-Lugano, Switzerland Business: Endocrine/Metabolic Helsinn granted Angelini's CSC Pharmaceuticals Handels GmbH subsidiary exclusive rights to commercialize …

    Published on 1/27/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993